Adaptogens Market By Source (Ashwagandha, Ginseng, Astragalus, Holy Basils, Rhodiola Roseas, Schisandra, Adaptogenic mushrooms, Others), By End Use (Powder, Capsules, Teas and Beverages, Others), By Application ( Food and Beverages, Dietary and sports supplements, Cosmetics, Animal Feed, Pharmaceutical), By Distribution Channel (Business to Business, Business to Consumer): Global Opportunity Analysis and Industry Forecast, 2021-2031
The adaptogens market size was valued at $10,320.2 million in 2021, and is projected to reach $20,328.6 million by 2031, registering a CAGR of 7.3% from 2022 to 2031. Adaptogen is meant to provide the herb that helps the body to regulate its natural metabolism and achieve balance. It helps in lowering mental stress.. Adaptogen plants are found in severe climates, for instance ashwagandha grows in desert. Ingredients such as ashwagandha and the holy basil have been linked to variety of health benefits including ashwagandha's ability to improve sleep. Ginseng, rohdiola, and schisandra are helpful in dealing with acute stress triggers in the body. Ginseng is used to improve the immune system of the body. Among all the adaptogens, ashwagandha has a major market share due to its health benefits.
Adaptogens are available in many forms such as adaptogen teas and the pre mixed powder consisting of adaptogens that can be consumed with food & in the form of capsules. Among all these forms, premix powder of adaptogen has a major market share due to its ability to be consumed with food as well as by mixing in liquid such as water.
The major factors that drive the growth of the adaptogens market are rise in amount of stress among consumers across the globe. In the study of American Institute of Stress, it was founded that about 73% people have stress, which impacts their mental health where as 48% of the people have trouble in sleeping due to stress.
According to the reports of global organization of stress, it was founded that almost 75% of the people experience moderate to high level of stress in the recent years. And to cure such kind of stress, adaptogen are prone to be a novel pharmaceutical solution to it. In addition, rise in demand for adaptogen from beverage industry and healthy food consumers, as adaptogen is available in powder form which help to reduce anxiety and increase the mental stability.Based on application, the adaptogen market is segmented into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceuticals. Among all the segments food and beverages are holding the largest market share because the usage of adaptogen in meals and in the form of beverages such as tea as a supplement.
Asia-Pacific has a large share for the global adaptogen market. The growth is owing to the fact that the adaptogens are broadly used in ayurveda, which is widely practiced in India and ultimately results in substantial market growth in India. Other Asian countries such as South Korea and China are among the biggest users of adaptogens in traditional medicine. Moreover, rise in the demand from emerging economies and the increase in usage of adaptogens in food & beverage and dietary & sports supplements are going to create new opportunities for the adaptogen market manufacturers in the upcoming future. However rise in the cost of research and development activities acts as a major factor as a restraint and is expected to be a further challenge for the adaptogen market in the upcoming future.
The Adaptogens market is segmented on the basis of source, end use, application, and region. On the basis of source, the market is classified into ashwagandha, ginseng, astragalus, holy basil, rhodiola roseas, schisandra, adaptogenic mushrooms, and others. Depending on end use, it is classified into powder, capsules, teas & beverages, and others. On the basis of application, it is classified into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceutical. By distribution channel, the market is classified into business to business, and business to consumer. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
According to the market players, the major obstacle attributed to the pandemic was the disruption of the supply chain. Furthermore, all the distribution channels were nearly shut down in the first quarter of the pandemic. However, online channels such as Amazon and Flipkart were delivering products. The key players included in the adaptogens market analysis are Dabur India Ltd, Emami Limited, kairali ayurvedic group, Himalaya Wellness, Colgate-Palmolive Company, Procter & Gamble, Patanjali Ayurved Limited, Shahnaz Ayurveda Pvt. Ltd., Shree Baidyanath Ayurveda Bhawan Pvt. Ltd, Unilever, ENOMARK BIOTECH (ENOMARK HEALTHCARE), Riaan Wellness Pvt. Ltd., Givaudan International SA (NATUREX S.A.), PLT Health Solutions, and INDENA S.P.A.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the adaptogens market analysis from 2021 to 2031 to identify the prevailing adaptogens market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the adaptogens market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global adaptogens market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Source
Ashwagandha
Ginseng
Astragalus
Holy Basils
Rhodiola Roseas
Schisandra
Adaptogenic mushrooms
Others
By End Use
Powder
Capsules
Teas and Beverages
Others
By Application
Food and Beverages
Dietary and sports supplements
Cosmetics
Animal Feed
Pharmaceutical
By Distribution Channel
Business to Business
Business to Consumer
Sales channel
Supermarket and hypermarket
Specialty store
Pharmacies and drug stores
Others
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Italy
Germany
France
Spain
The Netherlands
Switzerland
Rest Of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Thailand
Rest Of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
Dabur India Ltd
Emami Limited
kairali ayurvedic group
Himalaya Wellness
Colgate-Palmolive Company
Procter & Gamble
Patanjali Ayurved Limited
Shahnaz Ayurveda Pvt. Ltd.
Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
Unilever
ENOMARK BIOTECH (ENOMARK HEALTHCARE)
Riaan Wellness Pvt. Ltd.
.Givaudan International SA (NATUREX S.A.)
PLT Health Solutions
INDENA S.P.A
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: ADAPTOGENS MARKET, BY SOURCE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Ashwagandha
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Ginseng
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Astragalus
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Holy Basils
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Rhodiola Roseas
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 Schisandra
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- 4.8 Adaptogenic mushrooms
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market analysis by country
- 4.9 Others
- 4.9.1 Key market trends, growth factors and opportunities
- 4.9.2 Market size and forecast, by region
- 4.9.3 Market analysis by country
- CHAPTER 5: ADAPTOGENS MARKET, BY END USE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Powder
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Capsules
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Teas and Beverages
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: ADAPTOGENS MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Food and Beverages
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Dietary and sports supplements
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Cosmetics
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Animal Feed
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Pharmaceutical
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
- CHAPTER 7: ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Business to Business
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Business to Consumer
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.3.4 Business to Consumer Adaptogens Market by Sales channel
- 7.3.4.1 Supermarket and hypermarket Market size and forecast, by region
- 7.3.4.2 Specialty store Market size and forecast, by region
- 7.3.4.3 Pharmacies and drug stores Market size and forecast, by region
- 7.3.4.4 Others Market size and forecast, by region
- CHAPTER 8: ADAPTOGENS MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Source
- 8.2.3 North America Market size and forecast, by End Use
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by Distribution Channel
- 8.2.5.1 North America Business to Consumer Adaptogens Market by Sales channel
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Source
- 8.2.6.1.2 Market size and forecast, by End Use
- 8.2.6.1.3 Market size and forecast, by Application
- 8.2.6.1.4 Market size and forecast, by Distribution Channel
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Source
- 8.2.6.2.2 Market size and forecast, by End Use
- 8.2.6.2.3 Market size and forecast, by Application
- 8.2.6.2.4 Market size and forecast, by Distribution Channel
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Source
- 8.2.6.3.2 Market size and forecast, by End Use
- 8.2.6.3.3 Market size and forecast, by Application
- 8.2.6.3.4 Market size and forecast, by Distribution Channel
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Source
- 8.3.3 Europe Market size and forecast, by End Use
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by Distribution Channel
- 8.3.5.1 Europe Business to Consumer Adaptogens Market by Sales channel
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 UK
- 8.3.6.1.1 Market size and forecast, by Source
- 8.3.6.1.2 Market size and forecast, by End Use
- 8.3.6.1.3 Market size and forecast, by Application
- 8.3.6.1.4 Market size and forecast, by Distribution Channel
- 8.3.6.2 Italy
- 8.3.6.2.1 Market size and forecast, by Source
- 8.3.6.2.2 Market size and forecast, by End Use
- 8.3.6.2.3 Market size and forecast, by Application
- 8.3.6.2.4 Market size and forecast, by Distribution Channel
- 8.3.6.3 Germany
- 8.3.6.3.1 Market size and forecast, by Source
- 8.3.6.3.2 Market size and forecast, by End Use
- 8.3.6.3.3 Market size and forecast, by Application
- 8.3.6.3.4 Market size and forecast, by Distribution Channel
- 8.3.6.4 France
- 8.3.6.4.1 Market size and forecast, by Source
- 8.3.6.4.2 Market size and forecast, by End Use
- 8.3.6.4.3 Market size and forecast, by Application
- 8.3.6.4.4 Market size and forecast, by Distribution Channel
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Source
- 8.3.6.5.2 Market size and forecast, by End Use
- 8.3.6.5.3 Market size and forecast, by Application
- 8.3.6.5.4 Market size and forecast, by Distribution Channel
- 8.3.6.6 The Netherlands
- 8.3.6.6.1 Market size and forecast, by Source
- 8.3.6.6.2 Market size and forecast, by End Use
- 8.3.6.6.3 Market size and forecast, by Application
- 8.3.6.6.4 Market size and forecast, by Distribution Channel
- 8.3.6.7 Switzerland
- 8.3.6.7.1 Market size and forecast, by Source
- 8.3.6.7.2 Market size and forecast, by End Use
- 8.3.6.7.3 Market size and forecast, by Application
- 8.3.6.7.4 Market size and forecast, by Distribution Channel
- 8.3.6.8 Rest of Europe
- 8.3.6.8.1 Market size and forecast, by Source
- 8.3.6.8.2 Market size and forecast, by End Use
- 8.3.6.8.3 Market size and forecast, by Application
- 8.3.6.8.4 Market size and forecast, by Distribution Channel
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Source
- 8.4.3 Asia-Pacific Market size and forecast, by End Use
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by Distribution Channel
- 8.4.5.1 Asia-Pacific Business to Consumer Adaptogens Market by Sales channel
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 China
- 8.4.6.1.1 Market size and forecast, by Source
- 8.4.6.1.2 Market size and forecast, by End Use
- 8.4.6.1.3 Market size and forecast, by Application
- 8.4.6.1.4 Market size and forecast, by Distribution Channel
- 8.4.6.2 Japan
- 8.4.6.2.1 Market size and forecast, by Source
- 8.4.6.2.2 Market size and forecast, by End Use
- 8.4.6.2.3 Market size and forecast, by Application
- 8.4.6.2.4 Market size and forecast, by Distribution Channel
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Source
- 8.4.6.3.2 Market size and forecast, by End Use
- 8.4.6.3.3 Market size and forecast, by Application
- 8.4.6.3.4 Market size and forecast, by Distribution Channel
- 8.4.6.4 South Korea
- 8.4.6.4.1 Market size and forecast, by Source
- 8.4.6.4.2 Market size and forecast, by End Use
- 8.4.6.4.3 Market size and forecast, by Application
- 8.4.6.4.4 Market size and forecast, by Distribution Channel
- 8.4.6.5 Australia
- 8.4.6.5.1 Market size and forecast, by Source
- 8.4.6.5.2 Market size and forecast, by End Use
- 8.4.6.5.3 Market size and forecast, by Application
- 8.4.6.5.4 Market size and forecast, by Distribution Channel
- 8.4.6.6 Indonesia
- 8.4.6.6.1 Market size and forecast, by Source
- 8.4.6.6.2 Market size and forecast, by End Use
- 8.4.6.6.3 Market size and forecast, by Application
- 8.4.6.6.4 Market size and forecast, by Distribution Channel
- 8.4.6.7 Thailand
- 8.4.6.7.1 Market size and forecast, by Source
- 8.4.6.7.2 Market size and forecast, by End Use
- 8.4.6.7.3 Market size and forecast, by Application
- 8.4.6.7.4 Market size and forecast, by Distribution Channel
- 8.4.6.8 Rest of Asia-Pacific
- 8.4.6.8.1 Market size and forecast, by Source
- 8.4.6.8.2 Market size and forecast, by End Use
- 8.4.6.8.3 Market size and forecast, by Application
- 8.4.6.8.4 Market size and forecast, by Distribution Channel
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Source
- 8.5.3 LAMEA Market size and forecast, by End Use
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by Distribution Channel
- 8.5.5.1 LAMEA Business to Consumer Adaptogens Market by Sales channel
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Latin America
- 8.5.6.1.1 Market size and forecast, by Source
- 8.5.6.1.2 Market size and forecast, by End Use
- 8.5.6.1.3 Market size and forecast, by Application
- 8.5.6.1.4 Market size and forecast, by Distribution Channel
- 8.5.6.2 Middle East
- 8.5.6.2.1 Market size and forecast, by Source
- 8.5.6.2.2 Market size and forecast, by End Use
- 8.5.6.2.3 Market size and forecast, by Application
- 8.5.6.2.4 Market size and forecast, by Distribution Channel
- 8.5.6.3 Africa
- 8.5.6.3.1 Market size and forecast, by Source
- 8.5.6.3.2 Market size and forecast, by End Use
- 8.5.6.3.3 Market size and forecast, by Application
- 8.5.6.3.4 Market size and forecast, by Distribution Channel
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Dabur India Ltd
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Emami Limited
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 kairali ayurvedic group
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Himalaya Wellness
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Colgate-Palmolive Company
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Procter & Gamble
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Patanjali Ayurved Limited
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Shahnaz Ayurveda Pvt. Ltd.
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Unilever
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 ENOMARK BIOTECH (ENOMARK HEALTHCARE)
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 Riaan Wellness Pvt. Ltd.
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- 10.13 .Givaudan International SA (NATUREX S.A.)
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
- 10.14 PLT Health Solutions
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
- 10.15 INDENA S.P.A
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 2. ADAPTOGENS MARKET, FOR ASHWAGANDHA, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. ADAPTOGENS MARKET FOR ASHWAGANDHA, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. ADAPTOGENS MARKET, FOR GINSENG, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. ADAPTOGENS MARKET FOR GINSENG, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. ADAPTOGENS MARKET, FOR ASTRAGALUS, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. ADAPTOGENS MARKET FOR ASTRAGALUS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. ADAPTOGENS MARKET, FOR HOLY BASILS, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. ADAPTOGENS MARKET FOR HOLY BASILS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. ADAPTOGENS MARKET, FOR RHODIOLA ROSEAS, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. ADAPTOGENS MARKET FOR RHODIOLA ROSEAS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 12. ADAPTOGENS MARKET, FOR SCHISANDRA, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. ADAPTOGENS MARKET FOR SCHISANDRA, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. ADAPTOGENS MARKET, FOR ADAPTOGENIC MUSHROOMS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. ADAPTOGENS MARKET FOR ADAPTOGENIC MUSHROOMS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. GLOBAL ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 19. ADAPTOGENS MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. ADAPTOGENS MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. ADAPTOGENS MARKET, FOR CAPSULES, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. ADAPTOGENS MARKET FOR CAPSULES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. ADAPTOGENS MARKET, FOR TEAS AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. ADAPTOGENS MARKET FOR TEAS AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. GLOBAL ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 28. ADAPTOGENS MARKET, FOR FOOD AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. ADAPTOGENS MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. ADAPTOGENS MARKET, FOR DIETARY AND SPORTS SUPPLEMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. ADAPTOGENS MARKET FOR DIETARY AND SPORTS SUPPLEMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. ADAPTOGENS MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 33. ADAPTOGENS MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 34. ADAPTOGENS MARKET, FOR ANIMAL FEED, BY REGION, 2021-2031 ($MILLION)
- TABLE 35. ADAPTOGENS MARKET FOR ANIMAL FEED, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 36. ADAPTOGENS MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 37. ADAPTOGENS MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 38. GLOBAL ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 39. ADAPTOGENS MARKET, FOR BUSINESS TO BUSINESS, BY REGION, 2021-2031 ($MILLION)
- TABLE 40. ADAPTOGENS MARKET FOR BUSINESS TO BUSINESS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 41. ADAPTOGENS MARKET, FOR BUSINESS TO CONSUMER, BY REGION, 2021-2031 ($MILLION)
- TABLE 42. ADAPTOGENS MARKET FOR BUSINESS TO CONSUMER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 43. GLOBAL BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
- TABLE 44. ADAPTOGENS MARKET, FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 45. ADAPTOGENS MARKET, FOR SPECIALTY STORE, BY REGION, 2021-2031 ($MILLION)
- TABLE 46. ADAPTOGENS MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2021-2031 ($MILLION)
- TABLE 47. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 48. ADAPTOGENS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 49. NORTH AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 50. NORTH AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 51. NORTH AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 52. NORTH AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 53. NORTH AMERICA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
- TABLE 54. NORTH AMERICA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 55. U.S. ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 56. U.S. ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 57. U.S. ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 58. U.S. ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 59. CANADA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 60. CANADA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 61. CANADA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 62. CANADA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 63. MEXICO ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 64. MEXICO ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 65. MEXICO ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. MEXICO ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 67. EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 68. EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 69. EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 70. EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 71. EUROPE BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
- TABLE 72. EUROPE ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 73. UK ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 74. UK ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 75. UK ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 76. UK ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 77. ITALY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 78. ITALY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 79. ITALY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 80. ITALY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 81. GERMANY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 82. GERMANY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 83. GERMANY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. GERMANY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 85. FRANCE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 86. FRANCE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 87. FRANCE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 88. FRANCE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 89. SPAIN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 90. SPAIN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 91. SPAIN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 92. SPAIN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 93. THE NETHERLANDS ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 94. THE NETHERLANDS ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 95. THE NETHERLANDS ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 96. THE NETHERLANDS ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 97. SWITZERLAND ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 98. SWITZERLAND ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 99. SWITZERLAND ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 100. SWITZERLAND ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 101. REST OF EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 102. REST OF EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 103. REST OF EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 104. REST OF EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 105. ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 106. ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 107. ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 108. ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 109. ASIA-PACIFIC BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
- TABLE 110. ASIA-PACIFIC ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 111. CHINA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 112. CHINA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 113. CHINA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 114. CHINA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 115. JAPAN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 116. JAPAN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 117. JAPAN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 118. JAPAN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 119. INDIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 120. INDIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 121. INDIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 122. INDIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 123. SOUTH KOREA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 124. SOUTH KOREA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 125. SOUTH KOREA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 126. SOUTH KOREA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 127. AUSTRALIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 128. AUSTRALIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 129. AUSTRALIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 130. AUSTRALIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 131. INDONESIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 132. INDONESIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 133. INDONESIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 134. INDONESIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 135. THAILAND ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 136. THAILAND ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 137. THAILAND ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 138. THAILAND ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 139. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 140. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 141. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 142. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 143. LAMEA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 144. LAMEA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 145. LAMEA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 146. LAMEA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 147. LAMEA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
- TABLE 148. LAMEA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 149. LATIN AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 150. LATIN AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 151. LATIN AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 152. LATIN AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 153. MIDDLE EAST ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 154. MIDDLE EAST ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 155. MIDDLE EAST ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 156. MIDDLE EAST ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 157. AFRICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 158. AFRICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
- TABLE 159. AFRICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 160. AFRICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 161.DABUR INDIA LTD: COMPANY SNAPSHOT
- TABLE 162.DABUR INDIA LTD: OPERATING SEGMENTS
- TABLE 163.DABUR INDIA LTD: PRODUCT PORTFOLIO
- TABLE 164.DABUR INDIA LTD: NET SALES,
- TABLE 165.DABUR INDIA LTD: KEY STRATERGIES
- TABLE 166.EMAMI LIMITED: COMPANY SNAPSHOT
- TABLE 167.EMAMI LIMITED: OPERATING SEGMENTS
- TABLE 168.EMAMI LIMITED: PRODUCT PORTFOLIO
- TABLE 169.EMAMI LIMITED: NET SALES,
- TABLE 170.EMAMI LIMITED: KEY STRATERGIES
- TABLE 171.KAIRALI AYURVEDIC GROUP: COMPANY SNAPSHOT
- TABLE 172.KAIRALI AYURVEDIC GROUP: OPERATING SEGMENTS
- TABLE 173.KAIRALI AYURVEDIC GROUP: PRODUCT PORTFOLIO
- TABLE 174.KAIRALI AYURVEDIC GROUP: NET SALES,
- TABLE 175.KAIRALI AYURVEDIC GROUP: KEY STRATERGIES
- TABLE 176.HIMALAYA WELLNESS: COMPANY SNAPSHOT
- TABLE 177.HIMALAYA WELLNESS: OPERATING SEGMENTS
- TABLE 178.HIMALAYA WELLNESS: PRODUCT PORTFOLIO
- TABLE 179.HIMALAYA WELLNESS: NET SALES,
- TABLE 180.HIMALAYA WELLNESS: KEY STRATERGIES
- TABLE 181.COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT
- TABLE 182.COLGATE-PALMOLIVE COMPANY: OPERATING SEGMENTS
- TABLE 183.COLGATE-PALMOLIVE COMPANY: PRODUCT PORTFOLIO
- TABLE 184.COLGATE-PALMOLIVE COMPANY: NET SALES,
- TABLE 185.COLGATE-PALMOLIVE COMPANY: KEY STRATERGIES
- TABLE 186.PROCTER & GAMBLE: COMPANY SNAPSHOT
- TABLE 187.PROCTER & GAMBLE: OPERATING SEGMENTS
- TABLE 188.PROCTER & GAMBLE: PRODUCT PORTFOLIO
- TABLE 189.PROCTER & GAMBLE: NET SALES,
- TABLE 190.PROCTER & GAMBLE: KEY STRATERGIES
- TABLE 191.PATANJALI AYURVED LIMITED: COMPANY SNAPSHOT
- TABLE 192.PATANJALI AYURVED LIMITED: OPERATING SEGMENTS
- TABLE 193.PATANJALI AYURVED LIMITED: PRODUCT PORTFOLIO
- TABLE 194.PATANJALI AYURVED LIMITED: NET SALES,
- TABLE 19
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook